Clinical Trial Update: Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Ad5FGF-4 in patients with refractory angina due to myocardial ischemia is reported, with the status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Stable

Drugs mentioned

• Ad5FGF-4 (adenovirus type 5 fibroblast growth factor-4 gene therapy)

Snippet

Sponsor: Angionetics Inc. | Conditions: Angina, Stable | Phase 3 | Status: UNKNOWN